These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3390506)

  • 1. Estimating tumor incidence rates in animal carcinogenicity experiments.
    Dinse GE
    Biometrics; 1988 Jun; 44(2):405-15. PubMed ID: 3390506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of animal carcinogenicity experiments with multiple tumor types.
    Lu Y; Malani HM
    Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constant risk differences in the analysis of animal tumorigenicity data.
    Dinse GE
    Biometrics; 1991 Jun; 47(2):681-700. PubMed ID: 1912267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity.
    Bieler GS; Williams RL
    Biometrics; 1993 Sep; 49(3):793-801. PubMed ID: 8241374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiparametric analysis of tumor incidence rates in survival/sacrifice experiments.
    Portier CJ; Dinse GE
    Biometrics; 1987 Mar; 43(1):107-14. PubMed ID: 3567301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonparametric estimation of the survival function when cause of death is uncertain.
    Racine-Poon AH; Hoel DG
    Biometrics; 1984 Dec; 40(4):1151-8. PubMed ID: 6534414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-stage models of tumor incidence for historical control animals in the National Toxicology Program's carcinogenicity experiments.
    Portier CJ; Bailer AJ
    J Toxicol Environ Health; 1989; 27(1):21-45. PubMed ID: 2724366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment.
    Finkelstein DM
    Biometrics; 1991 Jun; 47(2):669-80. PubMed ID: 1912266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric methods for survival/sacrifice experiments.
    Dewanji A; Kalbfleisch JD
    Biometrics; 1986 Jun; 42(2):325-41. PubMed ID: 3741974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A measure of tumorigenic potency incorporating dose-response shape.
    Meier KL; Bailer AJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiparametric models for cumulative incidence functions.
    Bryant J; Dignam JJ
    Biometrics; 2004 Mar; 60(1):182-90. PubMed ID: 15032788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of carcinogenic potency from long-term animal carcinogenesis experiments.
    Sawyer C; Peto R; Bernstein L; Pike MC
    Biometrics; 1984 Mar; 40(1):27-40. PubMed ID: 6733232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples.
    Bailer AJ; Portier CJ
    Biometrics; 1988 Jun; 44(2):417-31. PubMed ID: 3390507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of interaction between carcinogens in long-term factorially designed animal experiments.
    Machado SG; Bailey KR
    Biometrics; 1985 Jun; 41(2):539-45. PubMed ID: 4027328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of age-adjusted tests in animal carcinogenicity experiments.
    Ryan LM
    Biometrics; 1985 Jun; 41(2):525-31. PubMed ID: 4027327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized tumor rates for chronic bioassays.
    Kodell RL; Gaylor DW; Chen JJ
    Biometrics; 1986 Dec; 42(4):867-73. PubMed ID: 3814727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.
    Peto R; Pike MC
    Biometrics; 1973 Sep; 29(3):579-84. PubMed ID: 4793138
    [No Abstract]   [Full Text] [Related]  

  • 19. A note on the bias of estimators with missing data.
    Rotnitzky A; Wypij D
    Biometrics; 1994 Dec; 50(4):1163-70. PubMed ID: 7786998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the probability of occurrence of tumor for a rare cancer with zero occurrence in a sample.
    Basu AP; Gaylor DW; Chen JJ
    Regul Toxicol Pharmacol; 1996 Apr; 23(2):139-44. PubMed ID: 8661332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.